An Update on the Current State of Management and Clinical Trials for IgA Nephropathy by Chee Kay Cheung, Arun Rajasekaran, Jonathan Barratt, Dana V. Rizk

Get full text

An Update on Current Therapeutic Options in IgA Nephropathy by Regina Shaoying Lim, See Cheng Yeo, Jonathan Barratt, Dana V. Rizk

Get full text

New Treatment Strategies for IgA Nephropathy: Targeting Plasma Cells as the Main Source of Pathogenic Antibodies by Dita Maixnerova, Delphine El Mehdi, Dana V. Rizk, Hong Zhang, Vladimir Tesar

Get full text

Colocalization of IgG and IgA Heavy Chains with Kappa and Lambda Light Chains in Glomerular Deposits of IgA Nephropathy Patients Using High-Resolution Confocal Microscopy and Corre... by Dana V. Rizk, Lea Novak, Stacy D. Hall, Zina Moldoveanu, Bruce A. Julian, Jan Novak, Mark Haas

Get full text

The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy by Dana V. Rizk, Nicolas Maillard, Bruce A. Julian, Barbora Knoppova, Barbora Knoppova, Todd J. Green, Jan Novak, Robert J. Wyatt

Get full text

Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy. by William J Placzek, Hiroyuki Yanagawa, Yuko Makita, Matthew B Renfrow, Bruce A Julian, Dana V Rizk, Yusuke Suzuki, Jan Novak, Hitoshi Suzuki

Get full text

Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study by Dana V. Rizk, Brad H. Rovin, Hong Zhang, Naoki Kashihara, Bart Maes, Hernán Trimarchi, Vlado Perkovic, Matthias Meier, Dmitrij Kollins, Olympia Papachristofi, Alan Charney, Jonathan Barratt

Get full text

The origin and activities of IgA1-containing immune complexes in IgA nephropathy by Barbora eKnoppova, Colin eReily, Nicolas eMaillard, Dana V. Rizk, Zina eMoldoveanu, Jiri eMestecky, Milan eRaska, Milan eRaska, Matthew B. Renfrow, Bruce A. Julian, Jan eNovak

Get full text